Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

14. Juli 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1965


	Artikel 1 - 20 / 39290

	Bifidobacterium animalis subsp. lactis V9 improves quality of life in advanced gastrointestinal cancer through gut microbiota-metabolite modulation. ISME Commun Yang L, Liu Y, Li J, Lv J, Zhang Q, Cong M, Shi H, Zhang H. PMID: 42445733 [PubMed]
	A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma. Transl Cancer Res Xiao WT, Wu SQ, Han YR, Song JH, He JY. PMID: 42445408 [PubMed]
	DDR1 in esophageal squamous cell carcinoma: bioinformatics discovery and experimental validation. Transl Cancer Res Muad YA, Zhang L, Peng W, Ye L. PMID: 42445401 [PubMed]
	Accuracy of machine learning in detecting lymph node metastasis of esophageal cancer: a systematic review and meta-analysis. Transl Cancer Res Chen J, Weng J, Lin X. PMID: 42445376 [PubMed]
	Systemic Inflammation Response Index, Albumin, and Hemoglobin-Albumin-Lymphocyte-Platelet Score for Stage-Stratified Esophageal Cancer Discrimination: A Retrospective Case-Control Study. Cancer Manag Res Li Y, Cui Y, Liu M, Zhang J, Liu Y. PMID: 42445223 [PubMed]
	Prognostic value of pretreatment systemic immune-inflammation index for overall survival in esophageal squamous cell carcinoma in China: a systematic review and meta-analysis. J Thorac Dis He C, Chen K, Zhao Y, Ni L, He R, Zhang Y, Sun N, Li G, Lai Z. PMID: 42444965 [PubMed]
	CT-based deep learning predicts immunotherapy response in esophageal squamous cell cancer patients. J Thorac Dis Li T, Fan R, Liu Z, Xu S, Zhang X, Xu Z, Yi J, Wei Z, Wu W, Wu Y. PMID: 42444933 [PubMed]
	Response-adapted perioperative therapy for resectable esophageal cancer in the immunotherapy era: a narrative review. J Thorac Dis Yan Y, Lyu J, Chen Y, Leng X. PMID: 42444886 [PubMed]
	Development and validation of a clinically interpretable risk scoring system for predicting one-year all-cause mortality in esophageal cancer: a population-based study. J Thorac Dis Lin H, Ma M, Fei W, Lu Q, He B. PMID: 42444861 [PubMed]
	Prognostic role of hemoglobin, albumin, lymphocyte and platelet score in esophageal cancer: a systematic review and meta-analysis. J Thorac Dis Yang H, Luo Y, Hu Y. PMID: 42444857 [PubMed]
	Small cell carcinoma esophagus: A rare entity. J Pak Med Assoc Aimon S, Ahmed MA, Ali F, Khan H, Attiq M, Ghairat H. PMID: 42444230 [PubMed - indexed for MEDLINE]
	Squamous cell carcinoma antigen and carcinoembryonic antigen monitoring during post-definitive chemoradiotherapy surveillance for esophageal squamous cell carcinoma: JCOG2106A. Dis Esophagus Sakanaka K, Kato K, Machida R, Ito Y, Daiko H, Kajiwara T, Tsubosa Y, Minashi K, Abe T, Kojima T, Hara H, Kawakubo H, Tsunoda S, Watanabe M, Doki Y, Nagatani Y, Kimura Y, Sasaki K, Takeuchi H, Kitagawa Y. PMID: 42442351 [PubMed - indexed for MEDLINE]
	Long-term outcomes and exploratory analysis from a randomized phase 3 trial of radiation dose escalation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma. Drug Resist Updat Cheng Q, Dong B, Zhu W, Li J, Huang R, Lin X, Sun Z, Yang X, Liu L, He H, Su Y, Wang C, Kong Y, Wang W, He H, Zeng M, Pu J, Hu W, Bao Y, Liu Z, Ma J, Jiang H, Guo H, Xu Y, Chen M. PMID: 42442129 [PubMed - as supplied by publisher]
	A Randomized, Nivolumab-controlled, Phase 2 and Biomarker Study of Lomvastomig and Tobemstomig in Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus. Clin Cancer Res Wyrwicz L, Dechaphunkul A, Lee JS, Turpin A, Sultanbaev A, Hong MH, De La Fouchardière C, Alsina M, Sauri T, Asirwa F, Pernot S, Cho S, Saleh M, Bergamo F, Cohen R, Baeksgaard L, Lordick F, Kraus D, Heichinger C, Tran VL, Mücke M, Michielin F, McIntyre C, Madden-Raja K, Marbach D, Davydov II, Lopes R, Wilson S, Rutishauser T, Codarri Deak L, Kao H, Markert C, Kim SB. PMID: 42440370 [PubMed - as supplied by publisher]
	Intratumoral and peritumoral CT radiomics combined with clinical and hematologic inflammatory markers for predicting lymph node metastasis in esophageal squamous cell carcinoma: a retrospective single-center study. Radiol Med Yang X, Niu H, Yang Z, Ren J, Wang X, Deng K, Wu Q, Kang X, Zhao J, Liang C. PMID: 42440230 [PubMed - as supplied by publisher]
	Ocular metastasis from esophageal cancer: a systematic review and pooled analysis of individual-level case data. Surg Today Mylonakis A, Vasilakopoulou MP, Despotidis M, Sourgiadakis A, Stefanou D, Petrou PC, Chatziralli E, Schizas D. PMID: 42439921 [PubMed - as supplied by publisher]
	Feasibility and short-term outcomes of curative esophagectomy in octogenarian patients with esophageal cancer: a real-world retrospective study. BMC Geriatr Xu B, Xiong J, Xiang J, Yi M, Luo T, Wang H, Ran X, Liu J, Shi G, Fu M. PMID: 42437890 [PubMed - as supplied by publisher]
	Access to cancer medicines in Kenya: a scoping review of costs, financial toxicity, quality of life and policy impacts. Ecancermedicalscience Oketch JO, Onguru DO, Amolo SA. PMID: 42437071 [PubMed]
	Prognostic value of tertiary lymphoid structures in high-risk esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy. BMC Cancer Huang D, Han Y, Wu H, Wang Q, Teng X, Zhang H, Zhuang R, Ye X, Chen Y, Wu T, Ye P, Jiang H. PMID: 42432570 [PubMed - as supplied by publisher]
	The state of cancer in Somalia: a comprehensive six-year retrospective study. BMC Cancer Hussein AM. PMID: 42432552 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 39290

Seite 1 von 1965



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung